← The Wire
MDGLNasdaq
MADRIGAL PHARMACEUTICALS, INC.
Pharmaceutical Preparations · DE · CIK 1157601
Delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) and advancing a pipeline of MASH treatments
red 8-K · 90d
$11.08B
Market cap
$527.28
Last close
+2.9%
1D
+2.8%
5D
447K
Volume
Price · last 39 sessions+1.7%
May 4L $452.86 · H $539.89Jun 29
317
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 17, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 6, 20268-KExecutive ChangeApr 28, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEFINITIVE PROXY STATEMENTApr 28, 202610-K10-KFeb 19, 20268-KResults of OperationsFeb 19, 20268-KMaterial AgreementJan 30, 2026SC 13D/ASC 13D/ADec 12, 2025SC 13D/ASC 13D/ADec 12, 20258-KExecutive ChangeDec 11, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KReg FD DisclosureJul 30, 20258-KMaterial Agreement · Agreement TerminatedJul 22, 20258-KShareholder VoteJun 20, 202510-Q10-QMay 1, 20258-KResults of OperationsMay 1, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KExecutive ChangeApr 17, 20258-KExecutive Change · Reg FD DisclosureMar 11, 202510-K10-KFeb 26, 20258-KResults of OperationsFeb 26, 20258-KResults of OperationsJan 13, 2025SC 13GSC 13GNov 14, 202410-Q10-QOct 31, 20248-KResults of OperationsOct 31, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KExecutive Change · Shareholder VoteJun 27, 20248-KMaterial Agreement · Agreement TerminatedMay 7, 2024424B5424B5May 7, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 20248-KCompany UpdateApr 2, 20248-KMaterial AgreementMar 20, 2024424B5424B5Mar 20, 2024424B5424B5Mar 18, 20248-KReg FD Disclosure · Company UpdateMar 15, 20248-KExecutive ChangeFeb 28, 20248-KResults of OperationsFeb 28, 202410-K10-KFeb 28, 20248-KCompany UpdateJan 8, 2024SC 13GSC 13GNov 13, 20238-KResults of OperationsNov 6, 202310-Q10-QNov 6, 20238-KMaterial AgreementOct 2, 2023424B5424B5Oct 2, 2023424B5424B5Sep 28, 20238-KExecutive ChangeSep 25, 20238-KExecutive ChangeSep 14, 20238-KExecutive ChangeSep 13, 20238-KCompany UpdateSep 13, 2023SC 13GJHG PLC OWNS 10%Sep 8, 20238-KResults of OperationsAug 8, 202310-Q10-QAug 8, 20238-KCompany UpdateJul 17, 20238-KCompany UpdateJun 30, 2023SC 13DSC 13DJun 20, 20238-KExecutive ChangeJun 20, 20238-KBylaw Amendment · Shareholder VoteJun 20, 2023424B5424B5May 9, 20238-KMaterial AgreementMay 9, 20238-KResults of OperationsMay 9, 202310-Q10-QMay 9, 2023DEFA14ADEFA14AMay 1, 2023DEF 14ADEF 14AMay 1, 202310-K/A10-K/AMar 3, 20238-KResults of OperationsFeb 23, 202310-K10-KFeb 23, 20238-KMaterial Agreement · New Debt / ObligationFeb 9, 2023SC 13GSC 13GFeb 2, 20238-KCompany UpdateJan 10, 2023424B5424B5Dec 23, 2022
Insider Activity
In the 90 days to Mar 6, 2026: 6 sold $52.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Sibold William JohnPresident and CEO | Sell | 1,663 | $431.94 | $718K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 646 | $431.94 | $279K |
| Mar 6, 2026 | Taub RebeccaDirector | Sell | 491 | $431.94 | $212K |
| Mar 6, 2026 | Huntsman CaroleChief Commercial Officer | Sell | 419 | $431.94 | $181K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 420 | $426.86 | $179K |
| Mar 6, 2026 | Kelley Shannon TGeneral Counsel | Sell | 360 | $431.94 | $155K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 160 | $434.20 | $69K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 160 | $429.00 | $69K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 120 | $430.90 | $52K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 116 | $432.56 | $50K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 80 | $436.69 | $35K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 80 | $435.32 | $35K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 80 | $427.85 | $34K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 40 | $437.65 | $18K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 40 | $429.58 | $17K |
| Mar 6, 2026 | Dier MardiEVP and CFO | Sell | 40 | $425.08 | $17K |
| Mar 2, 2026 | Dier MardiEVP and CFO | Sell | 1,183 | $427.21 | $505K |
| Jan 26, 2026 | Sibold William JohnPresident and CEO | Sell | 1,577 | $492.42 | $777K |
| Jan 26, 2026 | Taub RebeccaDirector | Sell | 647 | $492.42 | $319K |
| Jan 26, 2026 | Huntsman CaroleChief Commercial Officer | Sell | 570 | $494.59 | $282K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance